These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Amyloid-β dimers in the absence of plaque pathology impair learning and synaptic plasticity. Müller-Schiffmann A; Herring A; Abdel-Hafiz L; Chepkova AN; Schäble S; Wedel D; Horn AH; Sticht H; de Souza Silva MA; Gottmann K; Sergeeva OA; Huston JP; Keyvani K; Korth C Brain; 2016 Feb; 139(Pt 2):509-25. PubMed ID: 26657517 [TBL] [Abstract][Full Text] [Related]
6. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease. Jackson RJ; Rudinskiy N; Herrmann AG; Croft S; Kim JM; Petrova V; Ramos-Rodriguez JJ; Pitstick R; Wegmann S; Garcia-Alloza M; Carlson GA; Hyman BT; Spires-Jones TL Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574 [TBL] [Abstract][Full Text] [Related]
7. beta-amyloid deposits in transgenic mice expressing human beta-amyloid precursor protein have the same characteristics as those in Alzheimer's disease. Terai K; Iwai A; Kawabata S; Tasaki Y; Watanabe T; Miyata K; Yamaguchi T Neuroscience; 2001; 104(2):299-310. PubMed ID: 11377835 [TBL] [Abstract][Full Text] [Related]
9. The amyloid cascade hypothesis has misled the pharmaceutical industry. Biochem Soc Trans; 2011 Aug; 39(4):920-3. PubMed ID: 21787324 [TBL] [Abstract][Full Text] [Related]
10. Amelioration of cognitive deficits in plaque-bearing Alzheimer's disease model mice through selective reduction of nascent soluble Aβ42 without affecting other Aβ pools. Mitani Y; Yarimizu J; Akashiba H; Shitaka Y; Ni K; Matsuoka N J Neurochem; 2013 May; 125(3):465-72. PubMed ID: 23240999 [TBL] [Abstract][Full Text] [Related]
11. N-truncated Aβ Wirths O; Walter S; Kraus I; Klafki HW; Stazi M; Oberstein TJ; Ghiso J; Wiltfang J; Bayer TA; Weggen S Alzheimers Res Ther; 2017 Oct; 9(1):80. PubMed ID: 28978359 [TBL] [Abstract][Full Text] [Related]
12. Reverse relationship between beta-amyloid precursor protein and beta-amyloid peptide plaques in Down's syndrome versus sporadic/familial Alzheimer's disease. Egensperger R; Weggen S; Ida N; Multhaup G; Schnabel R; Beyreuther K; Bayer TA Acta Neuropathol; 1999 Feb; 97(2):113-8. PubMed ID: 9928821 [TBL] [Abstract][Full Text] [Related]
13. Amyloid-β immunotherapy reduces amyloid plaques and astroglial reaction in aged domestic dogs. Neus Bosch M; Pugliese M; Andrade C; Gimeno-Bayón J; Mahy N; Rodriguez MJ Neurodegener Dis; 2015; 15(1):24-37. PubMed ID: 25531153 [TBL] [Abstract][Full Text] [Related]
14. Spatial relationship of AMY protein deposits and different species of Abeta peptides in amyloid plaques of the Alzheimer disease brain. Schmidt ML; Saido TC; Lee VM; Trojanowski JQ J Neuropathol Exp Neurol; 1999 Dec; 58(12):1227-33. PubMed ID: 10604747 [TBL] [Abstract][Full Text] [Related]
15. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library. Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663 [TBL] [Abstract][Full Text] [Related]
16. An anti-pyroglutamate-3 Aβ vaccine reduces plaques and improves cognition in APPswe/PS1ΔE9 mice. Frost JL; Liu B; Rahfeld JU; Kleinschmidt M; O'Nuallain B; Le KX; Lues I; Caldarone BJ; Schilling S; Demuth HU; Lemere CA Neurobiol Aging; 2015 Dec; 36(12):3187-3199. PubMed ID: 26453001 [TBL] [Abstract][Full Text] [Related]
20. Amyloid-beta: a (life) preserver for the brain. Obrenovich ME; Joseph JA; Atwood CS; Perry G; Smith MA Neurobiol Aging; 2002; 23(6):1097-9. PubMed ID: 12470809 [No Abstract] [Full Text] [Related] [Next] [New Search]